1. Home
  2. GERN vs IBCP Comparison

GERN vs IBCP Comparison

Compare GERN & IBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GERN
  • IBCP
  • Stock Information
  • Founded
  • GERN 1990
  • IBCP 1864
  • Country
  • GERN United States
  • IBCP United States
  • Employees
  • GERN N/A
  • IBCP N/A
  • Industry
  • GERN Biotechnology: Pharmaceutical Preparations
  • IBCP Major Banks
  • Sector
  • GERN Health Care
  • IBCP Finance
  • Exchange
  • GERN Nasdaq
  • IBCP Nasdaq
  • Market Cap
  • GERN 823.0M
  • IBCP 682.2M
  • IPO Year
  • GERN 1996
  • IBCP N/A
  • Fundamental
  • Price
  • GERN $1.24
  • IBCP $32.22
  • Analyst Decision
  • GERN Buy
  • IBCP Hold
  • Analyst Count
  • GERN 7
  • IBCP 3
  • Target Price
  • GERN $3.17
  • IBCP $36.00
  • AVG Volume (30 Days)
  • GERN 7.6M
  • IBCP 122.0K
  • Earning Date
  • GERN 11-06-2025
  • IBCP 10-28-2025
  • Dividend Yield
  • GERN N/A
  • IBCP 3.22%
  • EPS Growth
  • GERN N/A
  • IBCP N/A
  • EPS
  • GERN N/A
  • IBCP 3.06
  • Revenue
  • GERN $164,447,000.00
  • IBCP $217,457,000.00
  • Revenue This Year
  • GERN $172.62
  • IBCP N/A
  • Revenue Next Year
  • GERN $56.87
  • IBCP $5.56
  • P/E Ratio
  • GERN N/A
  • IBCP $10.54
  • Revenue Growth
  • GERN 11877.20
  • IBCP 2.56
  • 52 Week Low
  • GERN $1.09
  • IBCP $26.75
  • 52 Week High
  • GERN $4.50
  • IBCP $40.32
  • Technical
  • Relative Strength Index (RSI)
  • GERN 43.70
  • IBCP 55.99
  • Support Level
  • GERN $1.19
  • IBCP $30.55
  • Resistance Level
  • GERN $1.31
  • IBCP $32.52
  • Average True Range (ATR)
  • GERN 0.07
  • IBCP 0.75
  • MACD
  • GERN -0.01
  • IBCP 0.14
  • Stochastic Oscillator
  • GERN 17.31
  • IBCP 85.29

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About IBCP Independent Bank Corporation

Independent Bank Corp (Ionia MI) operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers.

Share on Social Networks: